FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034685098> ?p ?o ?g. }

• W2034685098 endingPage "12" @default.
• W2034685098 startingPage "7" @default.
• W2034685098 abstract "To compare the long-term effect of disease-modifying therapies (DMT) on brain volume loss in relapsing-remitting MS (RRMS) patients.We conducted a study to examine the effect of daily glatiramer acetate (GA), weekly low dose interferon beta (LD-IFNB), and high-dose high-frequency interferon beta disease (HD-IFNB) on brain volume loss over 5 years in RRMS patients. All patients were previously treatment naïve, had disease duration ≤5 years at the time of initiating DMT, and subsequently received the same DMT for 5 years continuously. The percentage change in brain volume (PCBV) was measured using fully automated software. MRI analysis was performed blinded to treatment allocation.The adjusted PCBV from baseline to year 5 was -2.27% in GA, -2.62% in LD-IFNB, and -3.21% in the HD-IFNB groups (-2.27 vs -2.62, p=0.0036; -2.27 vs -3.21, p<0.0001; -2.62 vs -3.21, p<0.0001). These data remained unchanged from year 1 to year 5, after adjusting for pseudoatrophy in the first year. A group of RRMS patients that remained untreated for a period ranging from 8 to 24 months, served as controls. All treatment groups were significantly better than the rate of projected brain volume loss in the untreated group over 5 years (p<0.0001).Global brain volume loss is a dynamic process even in relatively early RRMS patients that occurs despite intervention with therapy. However, all DMT significantly reduced the loss of brain volume compared to no treatment. The GA-treated group experienced the least reduction in brain volume over 5 years, compared to the LD-IFNB and HD-IFNB treated groups. These differences could be partly related to the immunologic consequences of GA therapy in RRMS." @default.
• W2034685098 created "2016-06-24" @default.
• W2034685098 creator A5000584276 @default.
• W2034685098 creator A5039473753 @default.
• W2034685098 creator A5042668456 @default.
• W2034685098 creator A5048836412 @default.
• W2034685098 creator A5051172260 @default.
• W2034685098 creator A5072656514 @default.
• W2034685098 creator A5079146044 @default.
• W2034685098 creator A5081342306 @default.
• W2034685098 date "2012-01-01" @default.
• W2034685098 modified "2023-10-16" @default.
• W2034685098 title "Effect of disease-modifying therapies on brain volume in relapsing–remitting multiple sclerosis: Results of a five-year brain MRI study" @default.
• W2034685098 cites W1839179071 @default.
• W2034685098 cites W1978243650 @default.
• W2034685098 cites W1988037885 @default.
• W2034685098 cites W1993417921 @default.
• W2034685098 cites W1997577436 @default.
• W2034685098 cites W2014771080 @default.
• W2034685098 cites W2026402754 @default.
• W2034685098 cites W2026489629 @default.
• W2034685098 cites W2028942474 @default.
• W2034685098 cites W2029817323 @default.
• W2034685098 cites W2041757950 @default.
• W2034685098 cites W2063110337 @default.
• W2034685098 cites W2073931714 @default.
• W2034685098 cites W2079271961 @default.
• W2034685098 cites W2087844435 @default.
• W2034685098 cites W2089793429 @default.
• W2034685098 cites W2092043695 @default.
• W2034685098 cites W2099210971 @default.
• W2034685098 cites W2110553599 @default.
• W2034685098 cites W2115989506 @default.
• W2034685098 cites W2129615089 @default.
• W2034685098 cites W2132228594 @default.
• W2034685098 cites W2132487252 @default.
• W2034685098 cites W2148814846 @default.
• W2034685098 cites W2151041276 @default.
• W2034685098 cites W2151162595 @default.
• W2034685098 cites W2151576334 @default.
• W2034685098 cites W2164556363 @default.
• W2034685098 cites W2166983650 @default.
• W2034685098 cites W2473645617 @default.
• W2034685098 cites W3026077775 @default.
• W2034685098 cites W4244028742 @default.
• W2034685098 cites W4366064463 @default.
• W2034685098 cites W4376522286 @default.
• W2034685098 doi "https://doi.org/10.1016/j.jns.2011.08.034" @default.
• W2034685098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21920559" @default.
• W2034685098 hasPublicationYear "2012" @default.
• W2034685098 type Work @default.
• W2034685098 sameAs 2034685098 @default.
• W2034685098 citedByCount "33" @default.
• W2034685098 countsByYear W20346850982012 @default.
• W2034685098 countsByYear W20346850982013 @default.
• W2034685098 countsByYear W20346850982014 @default.
• W2034685098 countsByYear W20346850982015 @default.
• W2034685098 countsByYear W20346850982016 @default.
• W2034685098 countsByYear W20346850982017 @default.
• W2034685098 countsByYear W20346850982019 @default.
• W2034685098 countsByYear W20346850982020 @default.
• W2034685098 countsByYear W20346850982021 @default.
• W2034685098 countsByYear W20346850982023 @default.
• W2034685098 crossrefType "journal-article" @default.
• W2034685098 hasAuthorship W2034685098A5000584276 @default.
• W2034685098 hasAuthorship W2034685098A5039473753 @default.
• W2034685098 hasAuthorship W2034685098A5042668456 @default.
• W2034685098 hasAuthorship W2034685098A5048836412 @default.
• W2034685098 hasAuthorship W2034685098A5051172260 @default.
• W2034685098 hasAuthorship W2034685098A5072656514 @default.
• W2034685098 hasAuthorship W2034685098A5079146044 @default.
• W2034685098 hasAuthorship W2034685098A5081342306 @default.
• W2034685098 hasConcept C126322002 @default.
• W2034685098 hasConcept C126838900 @default.
• W2034685098 hasConcept C143409427 @default.
• W2034685098 hasConcept C203014093 @default.
• W2034685098 hasConcept C2778577042 @default.
• W2034685098 hasConcept C2780640218 @default.
• W2034685098 hasConcept C2989005 @default.
• W2034685098 hasConcept C3020694758 @default.
• W2034685098 hasConcept C65835030 @default.
• W2034685098 hasConcept C71924100 @default.
• W2034685098 hasConcept C90924648 @default.
• W2034685098 hasConceptScore W2034685098C126322002 @default.
• W2034685098 hasConceptScore W2034685098C126838900 @default.
• W2034685098 hasConceptScore W2034685098C143409427 @default.
• W2034685098 hasConceptScore W2034685098C203014093 @default.
• W2034685098 hasConceptScore W2034685098C2778577042 @default.
• W2034685098 hasConceptScore W2034685098C2780640218 @default.
• W2034685098 hasConceptScore W2034685098C2989005 @default.
• W2034685098 hasConceptScore W2034685098C3020694758 @default.
• W2034685098 hasConceptScore W2034685098C65835030 @default.
• W2034685098 hasConceptScore W2034685098C71924100 @default.
• W2034685098 hasConceptScore W2034685098C90924648 @default.
• W2034685098 hasIssue "1-2" @default.
• W2034685098 hasLocation W20346850981 @default.
• W2034685098 hasLocation W20346850982 @default.
• W2034685098 hasOpenAccess W2034685098 @default.

• next